UY34748A - HETEROCYCLIC COMPOUNDS AND THEIR USES - Google Patents

HETEROCYCLIC COMPOUNDS AND THEIR USES

Info

Publication number
UY34748A
UY34748A UY0001034748A UY34748A UY34748A UY 34748 A UY34748 A UY 34748A UY 0001034748 A UY0001034748 A UY 0001034748A UY 34748 A UY34748 A UY 34748A UY 34748 A UY34748 A UY 34748A
Authority
UY
Uruguay
Prior art keywords
inflammatory
diseases
treatment
conditions
bladder
Prior art date
Application number
UY0001034748A
Other languages
Spanish (es)
Inventor
Bui Minna
Timothy David Cushing
Felix Gonzalez Lopez De Turiso
Hao Xiaolin
Lucas Brian
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Priority to UY0001034748A priority Critical patent/UY34748A/en
Publication of UY34748A publication Critical patent/UY34748A/en

Links

Abstract

Heteroarilos bicíclicos sustituidos y composiciones que los contienen, para el tratamiento de inflamación general, artritis, enfermedades reumáticas, osteoartritis, enfermedades inflamatorias intestinales y oculares, enfermedades inflamatorias de la vejiga o vejiga inestable, psoriasis, afecciones de la piel con componentes inflamatorios, condiciones inflamatorias crónicas, incluyendo, pero sin limitarse a, enfermedades autoinmunes como lupus eritematoso sistémico (SLE), miastenia grave, artritis reumatoidea, encefalomielitis diseminada aguda, púrpura trombocitopénica idiopática, esclerosis múltiple, síndrome de Sjoegren y anemia hemolítica autoimnune, condiciones alérgica incluyendo todas las formas de hipersensibilidad. La invención también da a conocer métodos para el tratamiento de cánceres que son mediados por, dependen de, o están asociados con, la actividad p110.Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel and eye diseases, inflammatory diseases of the bladder or unstable bladder, psoriasis, skin conditions with inflammatory components, inflammatory conditions Chronic, including, but not limited to, autoimmune diseases such as systemic lupus erythematosus (SLE), myasthenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiple sclerosis, Sjoegren syndrome and autoimnune hemolytic anemia, allergic conditions including all forms of hypersensitivity. The invention also discloses methods for the treatment of cancers that are mediated by, depend on, or are associated with, the p110 activity.

UY0001034748A 2013-04-16 2013-04-16 HETEROCYCLIC COMPOUNDS AND THEIR USES UY34748A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY0001034748A UY34748A (en) 2013-04-16 2013-04-16 HETEROCYCLIC COMPOUNDS AND THEIR USES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY0001034748A UY34748A (en) 2013-04-16 2013-04-16 HETEROCYCLIC COMPOUNDS AND THEIR USES

Publications (1)

Publication Number Publication Date
UY34748A true UY34748A (en) 2014-10-31

Family

ID=52283032

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001034748A UY34748A (en) 2013-04-16 2013-04-16 HETEROCYCLIC COMPOUNDS AND THEIR USES

Country Status (1)

Country Link
UY (1) UY34748A (en)
  • 2013

Similar Documents

Publication Publication Date Title
CR11053A (en) HETEROCICLICAL COMPOUNDS AND THEIR USES
CR20140503A (en) HETEROCICLICAL COMPOUNDS AND THEIR USES
DOP2021000112A (en) SUBSTITUTE PYRROLYZINE COMPOUNDS AND USES OF THEM
CO6630161A2 (en) Heterocyclic compounds and their uses
CL2017000372A1 (en) Novel compositions, uses and methods to make them.
PH12018500718A1 (en) Compounds useful as modulators of trpm8
MX2018005129A (en) Glucagon receptor agonists.
CU20150117A7 (en) TAU IMMUNOTHERAPY
UY37005A (en) REPLACED HYDROXYPYRIMIDINONES AS AGELISTS OF THE APELINA RECEIVER AND ITS USES
GT201700188A (en) ANTIBODIES AGAINST TAU AND ITS USES
CL2017000576A1 (en) Mk2 inhibitors and their uses
CL2016002615A1 (en) Heterocyclyl sulfones substituted with heteroaryl and their use against pain, stroke, mood disorders, epilepsy, schizophrenia and neurodegenerative disorders.
HK1247936A1 (en) Ultrapurified dsba and dsbc and methods of making and using the same
CL2017000113A1 (en) Site-directed mutagenic receptor mutagenesis expressed in myeloid d type 1 (trem-1) to reduce viscocity
DK3164356T3 (en) HYDROPYROLYSIS OF BIOMASSOUS RAW MATERIALS
EA201691002A1 (en) BICYCLIC HETEROARRYNAL INDOAL ANALOGUES SUITABLE AS ROR GAMMA MODULATORS
CL2016002281A1 (en) Il-21 antibodies
EP3119796A4 (en) Synthesis of bicyclic nucleosides
FR3043648B1 (en) PROPELLANT VOILURE OF AN AIRCRAFT
ZA202001150B (en) Enhanced production of rhamnolipids using at least two carbon sources
UY34748A (en) HETEROCYCLIC COMPOUNDS AND THEIR USES
CL2019000027A1 (en) Dosing regimens of lingo-1 antagonists and uses for the treatment of demyelinating disorders.
DK3466392T3 (en) DECOMPOSITION OF BODY REMAINS
GB2553569B (en) Prioritization of video sources
CR20150366A (en) METHODS TO INCREASE THE PERFORMANCE OF CROPS

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20210526